Position in GSK
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$8,387
New position
Shares Held
160
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#942
of 1,033 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Peterson Wealth Services holds $13,297,121 across 8 Drug Manufacturers - General names. GSK ranks #6 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,914 | $5,893,999 | |
| 2 | ABBV |
AbbVie Inc.
|
14,557 | $3,663,123 | |
| 3 | JNJ |
Johnson & Johnson
|
14,383 | $3,652,850 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
979 | $56,409 | |
| 5 | GRFS |
Grifols SA
|
1,521 | $10,768 | |
| 6 | GSK |
GSK plc
This page
|
160 | $8,387 | |
| 7 | AZN |
Astrazeneca PLC
|
42 | $7,964 | |
| 8 | AMGN |
Amgen Inc
|
10 | $3,621 |
All Filings in GSK
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,387 | 160 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||